Literature DB >> 19471483

In vivo dynamic human retinal blood flow imaging using ultra-high-speed spectral domain optical coherence tomography.

Brian White, Mark Pierce, Nader Nassif, Barry Cense, B Park, Guillermo Tearney, Brett Bouma, Teresa Chen, Johannes de Boer.   

Abstract

An ultra-high-speed spectral domain optical Doppler tomography (SD-ODT) system is used to acquire images of blood flow in a human retina in vivo, at 29,000 depth profiles (A-lines) per second and with data acquisition over 99% of the measurement time. The phase stability of the system is examined and image processing algorithms are presented that allow accurate determination of bi-directional Doppler shifts. Movies are presented of human retinal flow acquired at 29 frames per second with 1000 A-lines per frame over a time period of 3.28 seconds, showing accurate determination of vessel boundaries and time-dependent bi-directional flow dynamics in artery-vein pairs. The ultra-high-speed SD-ODT system allows visualization of the pulsatile nature of retinal blood flow, detects blood flow within the choroid and retinal capillaries, and provides information on the cardiac cycle. In summary, accurate video rate imaging of retinal blood flow dynamics is demonstrated at ocular exposure levels below 600 microW.

Entities:  

Year:  2003        PMID: 19471483     DOI: 10.1364/oe.11.003490

Source DB:  PubMed          Journal:  Opt Express        ISSN: 1094-4087            Impact factor:   3.894


  129 in total

Review 1.  Fiber optic in vivo imaging in the mammalian nervous system.

Authors:  Amit D Mehta; Juergen C Jung; Benjamin A Flusberg; Mark J Schnitzer
Journal:  Curr Opin Neurobiol       Date:  2004-10       Impact factor: 6.627

2.  High-resolution wide-field imaging of retinal and choroidal blood perfusion with optical microangiography.

Authors:  Lin An; Hrebesh M Subhush; David J Wilson; Ruikang K Wang
Journal:  J Biomed Opt       Date:  2010 Mar-Apr       Impact factor: 3.170

Review 3.  Methods and algorithms for optical coherence tomography-based angiography: a review and comparison.

Authors:  Anqi Zhang; Qinqin Zhang; Chieh-Li Chen; Ruikang K Wang
Journal:  J Biomed Opt       Date:  2015-10       Impact factor: 3.170

4.  OCT angiography by absolute intensity difference applied to normal and diseased human retinas.

Authors:  Daniel Ruminski; Bartosz L Sikorski; Danuta Bukowska; Maciej Szkulmowski; Krzysztof Krawiec; Grazyna Malukiewicz; Lech Bieganowski; Maciej Wojtkowski
Journal:  Biomed Opt Express       Date:  2015-07-06       Impact factor: 3.732

Review 5.  [Technical principles of OCT angiography].

Authors:  P P Fang; W M Harmening; P L Müller; M Lindner; T U Krohne; F G Holz
Journal:  Ophthalmologe       Date:  2016-01       Impact factor: 1.059

6.  Mapping the 3D Connectivity of the Rat Inner Retinal Vascular Network Using OCT Angiography.

Authors:  Conor Leahy; Harsha Radhakrishnan; Geoffrey Weiner; Jeffrey L Goldberg; Vivek J Srinivasan
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-09       Impact factor: 4.799

Review 7.  Molecular contrast optical coherence tomography: a review.

Authors:  Changhuei Yang
Journal:  Photochem Photobiol       Date:  2005 Mar-Apr       Impact factor: 3.421

8.  Application of maximum likelihood estimator in nano-scale optical path length measurement using spectral-domain optical coherence phase microscopy.

Authors:  S M R Motaghian Nezam; C Joo; G J Tearney; J F de Boer
Journal:  Opt Express       Date:  2008-10-27       Impact factor: 3.894

9.  Phase-stable swept source OCT angiography in human skin using an akinetic source.

Authors:  Zhe Chen; Mengyang Liu; Michael Minneman; Laurin Ginner; Erich Hoover; Harald Sattmann; Marco Bonesi; Wolfgang Drexler; Rainer A Leitgeb
Journal:  Biomed Opt Express       Date:  2016-07-12       Impact factor: 3.732

10.  Retinal imaging using commercial broadband optical coherence tomography.

Authors:  Hitesh Tanna; Adam M Dubis; Nazia Ayub; Diane M Tait; Jungtae Rha; Kimberly E Stepien; Joseph Carroll
Journal:  Br J Ophthalmol       Date:  2009-09-21       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.